Organization
Acurx Pharmaceuticals
1 clinical trial
Clinical trial
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection: A Phase 2A Open-Label Segment Followed by a Phase 2B Double-Blind Vancomycin-Controlled SegmentStatus: Active (not recruiting), Estimated PCD: 2023-10-03